Do phase III trials have clinical value?

被引：12
|
作者：
Fleischhacker, WW [1 ]
Hummer, M [1 ]
机构：
[1] Univ Innsbruck, Dept Biol Psychiat, A-6020 Innsbruck, Austria
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 1999年 / 19卷 / 05期
关键词：
D O I：
10.1097/00004714-199910000-00001
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：391 / 392
页数：2
相关论文
共 50 条
  • [1] What to Do With the Participants/Patients in Phase III Clinical Cancer Trials That Have Been Stopped by the FDA
    Meyskens, Frank L., Jr.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (12)
  • [2] Why Do Phase III Clinical Trials in Oncology Fail so Often?
    Amiri-Kordestani, Laleh
    Fojo, Tito
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (08) : 568 - 569
  • [3] The quality of clinical trials in neuroendocrine tumours; have we learnt from our mistakes? An evaluation of phase II and phase III clinical trials
    Hayes, Aimee R.
    Chan, David L. H.
    Chan, Bryan A.
    Pavlakis, Nick
    [J]. JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 (09)
  • [4] Do early phase trials predict clinical efficacy in subsequent phase III biomarker-enriched randomized trials?
    Udayakumar, Suji
    Thomson, Sasha
    Razak, Albiruni Ryan Abdul
    Chan, Kelvin K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [5] Uncertainty in the Translation of Preclinical Experiments to Clinical Trials. Why do Most Phase III Clinical Trials Fail?
    Lowenstein, Pedro R.
    Castro, Maria G.
    [J]. CURRENT GENE THERAPY, 2009, 9 (05) : 368 - 374
  • [6] Do Early Phase Oncology Trials Predict Clinical Efficacy in Subsequent Biomarker-Enriched Phase III Randomized Trials?
    Suji Udayakumar
    Sasha Thomson
    Albiruni R. Abdul Razak
    Kelvin K. W. Chan
    [J]. Targeted Oncology, 2022, 17 : 665 - 674
  • [7] Do Early Phase Oncology Trials Predict Clinical Efficacy in Subsequent Biomarker-Enriched Phase III Randomized Trials?
    Udayakumar, Suji
    Thomson, Sasha
    Razak, Albiruni R. Abdul
    Chan, Kelvin K. W.
    [J]. TARGETED ONCOLOGY, 2022, 17 (06) : 665 - 674
  • [8] Clinical trials in systemic lupus erythematosus: the dilemma-Why have phase III trials failed to confirm the promising results of phase II trials?
    Lorenzo-Vizcaya, Ana
    Isenberg, David Alan
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (02) : 169 - 174
  • [9] Interphase clinical trials: Phase III/Phase IV
    O'Quigley, J
    Xu, RH
    Blin, P
    Charpak, Y
    [J]. BIOMETRICAL JOURNAL, 1999, 41 (07) : 773 - 782
  • [10] How much do phase III trials cost?
    Asher Mullard
    [J]. Nature Reviews Drug Discovery, 2018, 17 : 777 - 777
12345